Session Type
Meeting
Search Results for Outcomes
Abstract Number: 253
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Code Blue events, or in-hospital patient emergencies, often require advanced cardiac life support (ACLS) and unfortunately can end in loss of life. Defining and measuring outcomes is an essential step for improvement in any process, but especially for a process as critical as Code Blues. In our institution, Code Blues are run by a […]
Abstract Number: 274
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Since the 1999 IOM report To Err is Humanhighlighted that up to 98,000 preventable deaths occur annually in U.S. hospitals, efforts have intensified to understand and eliminate preventable mortality. At our institution, we developed an in-person, near real-time, multidisciplinary mortality review to capture the insight of frontline providers and improve care. In the analysis presented […]
Abstract Number: 279
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Anemia is common in patients with HF with a prevalence ranging from 10-40%. Studies have shown that these patients have worse outcomes compared to those who don’t. The most common etiology remains iron deficiency and the updated 2017 HF guidelines state that for those patients who are diagnosed with iron deficiency anemia, intravenous iron […]
Abstract Number: 295
SHM Converge 2024
Background: Older adults are commonly discharged to skilled nursing facilities (SNFs) after hospitalization. It is not known how patients anticipate SNF discharges and what they prioritize. The aims of this study are to explore what matters most to older adults during their hospital to SNF care transition. Methods: We conducted a grounded theory qualitative study. […]
Abstract Number: 302
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Immobility in the hospital setting is associated with persistent inability to perform activities of daily living, increased length of stay, and decreased return to independent living; this loss of function is identified by patients as a commonly unaddressed barrier to discharge. The reasons for immobility are multifactorial; however, lack of provider interest or value […]
Abstract Number: 309
SHM Converge 2024
Background: In societies with an aging population, hospitalists manage patients with a multitude of comorbidities, and many have challenging social circumstances. Patients with high social risk tend to have poorer healthcare outcomes, yet it is unclear how prevalent social risk factors are among hospitalized patients. We studied the prevalence of social risk among hospitalized patients […]
Abstract Number: 312
Hospital Medicine 2020, Virtual Competition
Background: Background: Patients transferred between hospitals undergo a high-risk transition of care, where communication is asynchronous, information is commonly lost, and mortality is disproportionately high. Prior studies have shown that standardizing communication through checklists can improve outcomes, and conversely lost documentation has been associated with higher mortality. The lack of interoperability of electronic health records […]
Abstract Number: 339
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Currently, once-daily nebulized bronchodilator therapy is unavailable for patients with chronic obstructive pulmonary disease (COPD). Prior studies demonstrated that once-daily revefenacin (REV) doses of 88 and 175 µg produced significant bronchodilation in COPD patients. We report the pooled results of two replicate phase 3 efficacy trials. Methods: In these double-blind, placebo-controlled, parallel-group, 12-week trials […]
Abstract Number: 356
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: The American healthcare system is focused on promoting value; providing high quality care while paying close attention to associated costs. Studies have shown that admission to a teaching hospital is associated with better outcomes, reduced mortality, compared to nonteaching hospitals. It is not known whether the value proposition at academic hospitals is worthwhile for […]
Abstract Number: 359
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Hepatic encephalopathy (HE) is a common neurological complication in patients with cirrhosis. In addition to numerous morbidity-related issues, HE is associated with substantial economic burden. Treatment includes lactulose or rifaximin, a nonsystemic antibiotic that is indicated for reducing the risk of overt HE recurrence in adults. Rifaximin has also been shown to reduce the […]